With CRISPR being a key component of this revolution in treatments and even cures, the industry is seeing a massive increase in demand for clinical-grade guide RNA. Synthego has established itself as a front-runner in this arena with ever-expanding GMP manufacturing capabilities, exemplified by numerous client success stories as well as continuous innovations. Watch this webinar to learn how Synthego can enable you throughout early-phase research, process development, and clinical trials for CRISPR-based therapies and diagnostics.

In this webinar (third of a 3-part series), you will learn about the actionable next steps to start exploring options for sgRNA– RUO, INDe, and GMP-grade– no matter where you are on the discovery-to-clinic spectrum.